|
|
|
Loss of penicillinase plasmids of Staphylococcus aureus after treatment with L-ascorbic acid. CF Amábile-Cuevas, Mutation Research 207: 107-109, 1988. Decreased resistance to antibiotics and plasmid loss in plasmid-carrying strains of Staphylococcus aureus treated with ascorbic acid. CF Amábile-Cuevas, RM Piña-Zentella, ME Wah-Laborde, Mutation Research, 264: 119-125, 1991. Bacterial plasmids and gene flux. CF Amábile-Cuevas, ME Chicurel, Cell, 70: 189-199, 1992. Two-stage control of an oxidative stress regulon: the Escherichia coli SoxR protein triggers redox-inducible expression of the soxS regulatory gene. T Nunoshiba, E Hidalgo, CF Amábile-Cuevas, B Demple, Journal of Bacteriology, 174: 6054-6060, 1992. Antibiotic resistance: merely the tip of the iceberg of plasmid-driven bacterial evolution. CF Amábile-Cuevas, M Cárdenas-García. In: Antibiotic resistance: from molecular basics to therapeutic options (CF Amábile-Cuevas, ed.) RG Landes/Chapman & Hall, Austin/New York, pp 35-56, 1996. Bacterial regulated responses resulting in antibiotic resistance. CF Amábile-Cuevas, AM Fuentes. In: Antibiotic resistance: from molecular basics to therapeutic options (CF Amábile-Cuevas, ed.) RG Landes/Chapman & Hall, Austin/New York, pp 57-72, 1996. Antibiotic usage and antibiotic resistance in Latin America. JJ Calva, A Niebla-Pérez, V Rodríguez-Lemoine, JI Santos, CF Amábile-Cuevas. In: Antibiotic resistance: from molecular basics to therapeutic options (CF Amábile-Cuevas, ed.) RG Landes/Chapman & Hall, Austin/New York, pp 73-97, 1996. A possible role for plasmids in mediating the cell-cell proximity required for gene flux. CF Amábile-Cuevas, ME Chicurel, Journal of Theoretical Biology, 181: 237-243, 1996. Mercury induces multiple antibiotic resistance in Escherichia coli through activation of SoxR, a redox-sensing regulatory protein. AM Fuentes, CF Amábile-Cuevas, FEMS Microbiology Letters, 154: 385-388, 1997. Why are antibiotic resistance genes so resistant to elimination? AA Salyers, CF Amábile-Cuevas, Antimicrobial Agents and Chemotherapy, 41: 2321-2325, 1997. Nucleophilic reactions on 1-trifluoromethane-sulfonylpyridinium trifluoromethanesulfonate (triflylpyridinium triflate, TPT). Ring-opening and "unexpected" 1,4-dihydropyridine reaction products. RA Toscano, MC Hernández-Galindo, R Rosas, O García-Mellado, F Del Río Portilla, CF Amábile-Cuevas, C Alvarez-Toledano, Chemical and Pharmacochemical Bulletin. 45: 957-961, 1997 Antioxidant vitamins C and E affect the superoxide-mediated induction of the soxRS regulon of Escherichia coli. AM Fuentes, CF Amábile-Cuevas, Microbiology, 144: 1731-1736, 1998. Antibiotic resistance and prescription practices in developing countries. CF Amábile-Cuevas, R Cabrera, LY Fuchs, F Valenzuela, Methods in Microbiology, 27: 587-594, 1998. Do antibiotics maintain antibiotic resistance? JA Heinemann, RG Ankenbauer, CF Amábile-Cuevas, Drug Discovery Today, 5: 195-204, 2000. Synthesis, characterization and biological activity of N'-trifluoro-methanesulfonyl-2-aminopyridine. R Toscano, M Moya, C Amábile, G Penieres, C Alvarez, Heteroatom Chemistry, 11: 308-311, 2000. Comparative in vitro activity of moxifloxacin by E-test against Streptococcus pyogenes. CF Amábile-Cuevas, C Hermida-Escudero, R Vivar, Clinical Infectious Diseases, 32 (suppl. 1): S30-S32, 2001. Regulatory locus soxRS partially protects Escherichia coli against ozone. G Jiménez-Arribas, V Léautaud, CF Amábile-Cuevas, FEMS microbiology Letters, 195: 175-177, 2001. Differential activities of the SoxR protein of Escherichia coli: SoxS is not required for gene activation under iron deprivation. AM Fuentes, JJ Díaz-Mejía, R Maldonado-Rodríguez, CF Amábile-Cuevas, FEMS Microbiology Letters,201:271-275, 2001 Antibiotic resistance in oral commensal streptococci from healthy Mexicans and Cubans: resistance prevalence does not mirror antibiotic usage. JJ Díaz-Mejía, A Carbajal-Saucedo, CF Amábile-Cuevas FEMS Microbiology Letters, 217:173-176, 2002. Actividad in vitro de moxifloxacino frente a patógenos respiratorios en Iberoamérica. H López, H Sader, C Amábile, W Pedreira, JL Muñoz Bellido, JA García Rodríguez, Grupo MSP-LA. Revista Española de Quimioterapia, 15: 325-334, 2002. Shooting the messenger of antibiotic resistance: plasmid elimination as a potential counter-evolutionary tactic. CF Amábile-Cuevas, JA Heinemann. Drug Discovery Today, 9: 465-467, 2004. Comparison of antibiotic susceptibility and plasmid content, between biofilm producing and non-producing clinical isolates of Pseudomonas aeruginosa. F Delissalde, CF Amábile-Cuevas. International Journal of Antimicrobial Agents,24: 405-408, 2004. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study. JL Arredondo-García, R Figueroa-Damián, A Rosas, A Jáuregui, M Corral, A Costa, RM Merlos, A Ríos-Fabra, CF Amábile-Cuevas, GM Hernández-Oliva, J Olguín, O Cardeñosa-Guerra. Journal of Antimicrobial Chemotherapy, 54: 840-843, 2004. Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis, the Latin American cohort. J Urueta-Robledo, A Ariza, JR Jardim, A Caballero, A García-Calderón, CF Amábile-Cuevas, G Hernández-Oliva, R Vivar-Orozco. Respiratory Medicine, 100: 1504-1511, 2006. Urban dust fecal pollution in Mexico City: antibiotic resistace and virulence factors of Escherichia coli. I Rosas, E Salinas, L Martínez, E Calva, A Cravioto, C Eslava, CF Amábile-Cuevas. International Journal of Hygiene and Environmental Health, 209: 461-470, 2006. Moxifloxacin vs. amoxicillin/clavulanate in the treatment of acute sinusitis. JR Arrieta, AG Galgano, E Sakano, X Fonseca, CF Amábile-Cuevas, G Hernández-Oliva, R Vivar, G González, A Torres. American Journal of Otolaryngology, 28: 78-82. 2007. An analysis of the evolutionary relationships of integron integrases, with emphasis on the prevalence of class 1 integrons in Escherichia coli isolates from clinical and environmental origins. JJ Díaz-Mejía, CF Amábile-Cuevas, I Rosas, V Souza. Microbiology, 154: 94-102, 2008. High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City. JL Arredondo-García, CF Amábile-Cuevas. Journal of Infection in Developing Countries, 2: 350-353, 2008. Susceptibility of Mexican clinical isolates of yeasts and moulds, to amphotericin B and triazole antifungals. JL Arredondo-García, CF Amábile-Cuevas, RedMic2 Study Group. Journal of Infection in Developing Countries, 3: 398-401, 2009. Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections. R Vick-Fragoso, G Hernández-Oliva, J Cruz-Alcázar, CF Amábile-Cuevas, P Arvis, P Reimnitz, JR Bogner. Infection, 37: 407-417, 2009. Fluoroquinolone resistance in clinical and environmental isolates of Escherichia coli in Mexico City. CF Amábile-Cuevas, JL Arredondo-García, A Cruz, I Rosas. Journal of Applied Microbiology, 108: 158-162, 2010. Antibiotic resistance in Mexico: a brief overview of the current status and its causes. CF Amábile-Cuevas. Journal of Infection in Developing Countries, accepted. |
ARTICULOS
de INVESTIGACION
|